Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Bilastine 20 mg Tablets in Healthy Thai Volunteers
TCTR20250129004Phase 1Unknown
- Sponsor
- International Bio Service
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of bilastine in allergic rhinitis (AR) and urticaria (2 arms), sponsored by International Bio Service. Primary endpoint: Primary pharmacokinetic bioequivalence parameters. Status: unknown.
02
Drugs
bilastine
03
Conditions
allergic rhinitis (AR)urticaria
Beyond the preview
Go deeper on TCTR20250129004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250129004.